Methylpiperazine-based 1,2,4-triazole derivatives as potent DNA gyrase b inhibitors with promising broad-spectrum antimicrobial activity
| dc.contributor.author | Uygun Cebeci, Yıldız | |
| dc.contributor.author | Keşkek Karabulut, Yasemin | |
| dc.contributor.author | Ceylan, Şule | |
| dc.date.accessioned | 2026-07-06T13:38:08Z | |
| dc.date.available | 2026-07-06T13:38:08Z | |
| dc.date.issued | 2025 | |
| dc.department | AÇÜ, Artvin Meslek Yüksekokulu, Laboratuvar Teknolojisi Bölümü | |
| dc.description.abstract | Abstract: The emergence of antimicrobial resistance (AMR) poses a critical threat to global health, underscoring the need for new antimicrobial agents. In this study, a novel series of 1,2,4-triazole derivatives was synthesized from methylpiperazine intermediates via esterification, hydrazide formation, thiourea condensation, and Mannich-type reactions. Structural characterization was performed using FT-IR, 1H, 13C NMR, and EI-MS techniques. Antimicrobial activities of the synthesized compounds were evaluated via broth microdilution. One derivative displayed remarkable broad-spectrum activity with MIC values <0.24 µg/mL against E. coli, S. aureus, M. smegmatis, and C. albicans. Molecular docking against E. coli DNA gyrase B (PDB: 4PRV) revealed strong binding affinities for two derivatives (–9.9 and –9.8 kcal/mol), correlating well with in vitro results. Key interactions included hydrogen bonding, π–π stacking, and halogen bonding. SAR analysis emphasized the role of electron-withdrawing and hydrophobic groups in enhancing activity. These triazole derivatives show promise as potent antimicrobial candidates targeting DNA gyrase B. | |
| dc.identifier.doi | 10.1134/S1070363225602820 | |
| dc.identifier.endpage | 2910 | |
| dc.identifier.issn | 10703632 | |
| dc.identifier.issue | 10 | |
| dc.identifier.scopus | 2-s2.0-105020758225 | |
| dc.identifier.scopusquality | Q3 | |
| dc.identifier.startpage | 2900 | |
| dc.identifier.uri | https://hdl.handle.net/11494/6256 | |
| dc.identifier.volume | 95 | |
| dc.identifier.wos | WOS:001606918900013 | |
| dc.identifier.wosquality | Q4 | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | Web of Science | |
| dc.institutionauthor | Ceylan, Şule | |
| dc.language.iso | en | |
| dc.publisher | Pleiades Publishing | |
| dc.relation.ispartof | Russian Journal of General Chemistry | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | 1 | |
| dc.subject | 2 | |
| dc.subject | 4-triazole | |
| dc.subject | Antimicrobial activity | |
| dc.subject | DNA gyrase B inhibition | |
| dc.subject | Methylpiperazine | |
| dc.subject | Molecular docking | |
| dc.subject | Structure–activity relationship (SAR) | |
| dc.title | Methylpiperazine-based 1,2,4-triazole derivatives as potent DNA gyrase b inhibitors with promising broad-spectrum antimicrobial activity | |
| dc.type | Article |












